Literature DB >> 11988614

Quality of life measurement after stroke: uses and abuses of the SF-36.

Jeremy C Hobart1, Linda S Williams, Kimberly Moran, Alan J Thompson.   

Abstract

BACKGROUND AND
PURPOSE: The Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) is widely used to measure health status after stroke. However, a fundamental assumption for its valid use after stroke has not been comprehensively tested: is it legitimate to generate scores for 8 scales and 2 summary measures using the standard algorithms? We tested this assumption.
METHODS: SF-36 data from 177 people after stroke were examined (71% male; mean age, 62). We tested 6 scaling criteria to determine the legitimacy of generating the 8 SF-36 scale scores using Likert's method of summed ratings, and we tested 2 scaling criteria to determine the appropriateness of the standard SF-36 algorithms for weighting and combining scale scores to generate 2 summary measures (physical and mental).
RESULTS: Scaling assumptions were fully satisfied for 6 of the 8 scales, but 3 of these 6 scales had notable floor and/or ceiling effects. Assumptions for generating 2 SF-36 summary measures were not satisfied.
CONCLUSIONS: In this sample, 5 of the 8 SF-36 scales had limited validity as outcome measures after stroke, and the reporting of physical and mental summary scores was not supported. Results raise questions about the use of the SF-36 in stroke, and the SF-12 that is developed from it, and highlight the importance of testing scaling assumptions when applying existing scales to new populations.

Entities:  

Mesh:

Year:  2002        PMID: 11988614     DOI: 10.1161/01.str.0000015030.59594.b3

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  40 in total

Review 1.  A Systematic Review of Self-Management Interventions for Inflammatory Bowel Disease.

Authors:  Samantha Conley; Nancy Redeker
Journal:  J Nurs Scholarsh       Date:  2016-01-12       Impact factor: 3.176

2.  Initial validation of the Swedish version of the London Handicap Scale.

Authors:  Albert Westergren; Peter Hagell
Journal:  Qual Life Res       Date:  2006-09-13       Impact factor: 4.147

Review 3.  The impact of neuropsychological deficits on functional stroke outcomes.

Authors:  Suzanne Barker-Collo; Valery Feigin
Journal:  Neuropsychol Rev       Date:  2006-08-09       Impact factor: 7.444

4.  Quality of life amongst young adults with stroke living in Kenya.

Authors:  G Muli; A Rhoda
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

5.  Analyzing change in recovery patterns in the year after acute hospitalization.

Authors:  Janet A Prvu Bettger; Wendy J Coster; Nancy K Latham; Julie J Keysor
Journal:  Arch Phys Med Rehabil       Date:  2008-07       Impact factor: 3.966

6.  Measuring health-related quality of life for persons with mobility impairments: an enabled version of the short-form 36 (SF-36E).

Authors:  Katherine Froehlich-Grobe; Elena M Andresen; Charlene Caburnay; Glen W White
Journal:  Qual Life Res       Date:  2008-04-22       Impact factor: 4.147

7.  Quality of life related to swallowing after tongue cancer treatment.

Authors:  Anna Karinne Costa Bandeira; Elma H M Azevedo; José Guilherme Vartanian; Inês N Nishimoto; Luiz Paulo Kowalski; Elisabete Carrara-de Angelis
Journal:  Dysphagia       Date:  2007-11-13       Impact factor: 3.438

8.  Responsiveness of the Harris Hip Score and the SF-36: five years after total hip arthroplasty.

Authors:  Hon-Yi Shi; Lih-Wen Mau; Je-Ken Chang; Jun-Wen Wang; Herng-Chia Chiu
Journal:  Qual Life Res       Date:  2009-07-16       Impact factor: 4.147

9.  White matter hyperintensities and quality of life in acute lacunar stroke.

Authors:  W K Tang; H J Liang; Y K Chen; A T Ahuja; Winnie C W Chu; V C T Mok; Gabor S Ungvari; K S Wong
Journal:  Neurol Sci       Date:  2012-12-18       Impact factor: 3.307

10.  Testing the SF-36 in Parkinson's disease. Implications for reporting rating scale data.

Authors:  P Hagell; A L Törnqvist; J Hobart
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.